We also assessed whether there was a relationship between 18F-fluciclovine tumour uptake and three surrogate markers of clinical outcome in breast cancer that have previously been shown to correlate with breast tumour FDG uptake: grade, tumour Ki-67 expression and the neutrophil–lymphocyte ratio (NLR) [13, 14]. The gene discussed is MKI67; the disease is breast cancer.